Alpha Teknova, Inc. (NASDAQ:TKNO ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Jennifer Henry - Senior Vice President of Marketing Matthew C. Lowell - Chief Financial Officer Stephen Gunstream - President, CEO & Director Conference Call Participants Brendan Mychal Smith - TD Cowen, Research Division Matthew Moriarty Parisi - KeyBanc Capital Markets Inc., Research Division Matthew Richard Larew - William Blair & Company L.L.C.
Alpha Teknova, Inc. (NASDAQ:TKNO ) Q1 2025 Results Conference Call May 8, 2025 5:00 PM ET Company Participants Jennifer Henry - Senior Vice President, Marketing Stephen Gunstream - President and Chief Executive Officer Matt Lowell - Chief Financial Officer Conference Call Participants Anna Snopkowski - KeyBanc Matt Hewitt - Craig-Hallum Capital Group Matt Larew - William Blair Chad Wiatrowski - TD Cowen Operator Good day, and thank you for standing by. Welcome to the Teknova First Quarter 2025 Financial Results Conference Call.
Alpha Teknova, Inc. (NASDAQ:TKNO ) Q4 2024 Earnings Call March 4, 2025 5:00 PM ET Company Participants Jennifer Henry - Senior Vice President, Marketing Stephen Gunstream - President and Chief Executive Officer Matt Lowell - Chief Financial Officer Conference Call Participants Matt Larew - William Blair Matthew Parisi - KeyBanc Capital Markets Mark Massaro - BTIG Matt Hewitt - Craig-Hallum Operator Thank you for standing by, and welcome to Teknova's Fourth Quarter and Full Year 2024 Earnings Conference Call. [Operator Instructions] I would now like to hand the call over to Jennifer Henry, Senior Vice President of Marketing.
| Specialty Retail Industry | Consumer Discretionary Sector | Stephen Gunstream CEO | NASDAQ (NMS) Exchange | 02080L102 CUSIP |
| US Country | 173 Employees | - Last Dividend | - Last Split | 25 Jun 2021 IPO Date |
Alpha Teknova, Inc. is a company that plays a significant role in the life sciences sector, offering a broad range of critical reagents crucial for the research, discovery, development, and commercialization of innovative therapies, vaccines, and molecular diagnostics both in the domestic and international markets. Since its inception in 1996, the company has established a substantial presence, headquartered in Hollister, California, and has become a trusted supplier to the pharmaceutical and biotechnology industries, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. is dedicated to supporting the life sciences market by providing high-quality, reliable products essential for the advancement of medical science and healthcare.